AbbVie Executive and Leadership Team

Jeanne Martinez, the Regional Chief Financial Officer at AbbVie, directs financial strategy and operations across key geographic markets. This leadership role involves overseeing regional budgeting, forecasting, and financial planning to support AbbVie's global biopharmaceutical objectives. Martinez ensures fiscal discipline and optimizes resource allocation to drive sustainable growth and profitability in diverse international markets. The financial oversight provided by the Regional Chief Financial Officer is critical for managing regional investments and ensuring compliance with local financial regulations. By analyzing market trends and financial performance, Martinez guides regional financial decision-making, directly impacting the company's ability to deliver innovative medicines and health solutions worldwide. This executive's focus on regional financial health supports AbbVie's broader mission of addressing complex medical challenges.

Pinar Ceylan, the Director, Finance & Chief Financial Officer at AbbVie, directs the company's financial operations and strategic financial planning. This executive leadership role involves managing financial resources, overseeing budgeting, and ensuring fiscal responsibility across AbbVie's global enterprise. Ceylan guides financial strategies that support the discovery, development, and delivery of innovative medicines, contributing to sustainable growth and profitability. The Director, Finance & Chief Financial Officer ensures robust financial controls and provides critical insights for investment decisions, aligning financial objectives with the company's mission to address complex medical challenges. By maintaining financial integrity and driving strategic financial initiatives, Pinar Ceylan plays a vital role in AbbVie's ability to advance patient care and improve quality of life worldwide. This executive's financial acumen is foundational to the company's success.

Anjili Mathur, the Chief of Staff I Director II, Immunology Strategic Management at AbbVie, spearheads strategic initiatives within the immunology therapeutic area. This role involves coordinating cross-functional teams to advance the development and commercialization of innovative immunology treatments. Mathur ensures alignment between strategic objectives and operational execution, facilitating seamless progress from early-stage research to market delivery. The Chief of Staff I Director II, Immunology Strategic Management drives critical projects, manages stakeholder communications, and supports the executive leadership in navigating complex operational landscapes. By fostering collaboration and optimizing workflows, Anjili Mathur contributes significantly to AbbVie's mission of developing therapies for serious and life-altering diseases. This executive's strategic management is vital for accelerating the delivery of impactful solutions to patients.

Linda Ray, the Senior VP & Chief Information Officer at AbbVie, architects and executes the company's global information technology strategy. This leadership position involves overseeing all aspects of technology infrastructure, digital transformation, and cybersecurity to support AbbVie's biopharmaceutical operations. Ray drives innovation in IT systems, ensuring robust data management and advanced analytics capabilities that underpin drug discovery and development. The Senior VP & Chief Information Officer champions the adoption of cutting-edge technologies, enhancing operational efficiency and enabling data-driven decision-making across the organization. By securing critical information assets and fostering a culture of technological advancement, Linda Ray plays a pivotal role in AbbVie's pursuit of novel health solutions. This executive's vision for technology is fundamental to addressing complex medical challenges.

Nancy Radcliffe, the Senior Coordinator - Chief Revenue Officer and Trade Accounts at AbbVie, supports the strategic management of revenue streams and key trade partnerships. This role focuses on optimizing commercial relationships and ensuring effective account management to drive sales performance. Radcliffe coordinates activities that enhance revenue generation and strengthens collaborations with trade partners, crucial for delivering AbbVie's innovative medicines to patients. The Senior Coordinator - Chief Revenue Officer and Trade Accounts facilitates communication and operational alignment between commercial teams and external stakeholders. By managing trade accounts and supporting revenue initiatives, Nancy Radcliffe contributes to AbbVie's market presence and its ability to reach individuals with unmet medical needs. This executive's efforts are integral to the company's commercial success.

Valerie Menaker, the Director, Strategic Operations & Oncology Early Development Operations Chief of Staff at AbbVie, directs operational strategies for oncology early development. This critical role involves managing complex project timelines, resource allocation, and cross-functional coordination to accelerate the advancement of novel oncology therapies. Menaker ensures operational readiness and efficiency, supporting the seamless progression of early-stage research and clinical trials. The Director, Strategic Operations & Oncology Early Development Operations Chief of Staff fosters collaboration among research, development, and operational teams, driving progress in the fight against cancer. By optimizing operational frameworks, Valerie Menaker significantly contributes to AbbVie's commitment to developing life-altering treatments for patients facing serious diseases. This executive's leadership is key to bringing innovative oncology solutions to market.

Carla Stalfa, the Chief Marketing Officer & Trial Management Analyst at AbbVie, leads marketing strategies and oversees critical aspects of clinical trial management. This dual focus ensures that marketing efforts are informed by operational realities and that trial processes are optimized for maximum impact. Stalfa drives brand development and market positioning for AbbVie's diverse portfolio of innovative medicines, while also analyzing trial data to enhance patient outcomes. The Chief Marketing Officer & Trial Management Analyst bridges commercial insights with clinical execution, ensuring cohesive strategies that support patient access and therapeutic advancement. By integrating marketing acumen with analytical rigor, Carla Stalfa contributes to AbbVie's mission of addressing complex medical challenges and improving global health. This executive's comprehensive approach is vital for market success and patient well-being.

Mark Schacher, the Director, Data and Statistical Science and Chief of Staff at AbbVie, directs advanced data analytics and statistical methodologies to support scientific discovery and operational efficiency. This leadership position involves leveraging data to drive insights in drug development, clinical research, and business strategy. Schacher oversees teams responsible for statistical analysis, data modeling, and the implementation of data-driven decision-making processes across the organization. The Director, Data and Statistical Science and Chief of Staff ensures the integrity and application of scientific data, contributing to the development of innovative health solutions. By advancing statistical science and providing strategic operational support, Mark Schacher plays a crucial role in AbbVie's commitment to tackling complex medical challenges and improving patient lives. This executive's expertise in data is fundamental to scientific progress.

Brian Szopinski, the Director, Clinical Operations & Chief of Staff at AbbVie, oversees the execution of clinical trials and provides strategic operational support. This role is central to ensuring the efficient and effective conduct of studies that advance AbbVie's pipeline of innovative medicines. Szopinski manages clinical operations, coordinating site activities, patient recruitment, and data collection to meet rigorous scientific and regulatory standards. The Director, Clinical Operations & Chief of Staff ensures operational alignment with strategic goals, facilitating the smooth progression of therapeutic development. By optimizing clinical trial processes and providing executive-level operational guidance, Brian Szopinski significantly contributes to AbbVie's mission of delivering groundbreaking health solutions. This executive's leadership is essential for bringing new treatments to patients.

Sarah Kopecky-Bromberg, the Strategic Planning Director, Development & Operations, Specialty Chief of Staff at AbbVie, drives strategic planning for specialty therapeutic development and operations. This leadership role involves shaping the strategic direction and operational execution for key specialty areas, ensuring alignment with AbbVie's broader mission. Kopecky-Bromberg coordinates strategic initiatives, identifies opportunities for operational improvement, and supports executive decision-making to advance the development of specialized medicines. The Strategic Planning Director, Development & Operations, Specialty Chief of Staff fosters collaboration across development and operational teams, enhancing the efficiency of bringing complex therapies to market. By guiding strategic planning, Sarah Kopecky-Bromberg contributes significantly to AbbVie's commitment to addressing unmet medical needs and improving patient outcomes. This executive's strategic foresight is critical for innovation.